One Free MANF catalyst will be the GDNF Phase 2b results coming out very soon. If the renshaw blood brain barrier technology works for GDNF (Parkinsons), and MANF has tested to be better than GDNF, we could get a free boost from that....out of nowhere!

Eventhough MANF/PD commercialization would be 8 years away, positive news on GDNF would cause us to speed up our IND and get us closer to someone wanting to partner with us on it.

The more MANF indications that get into the spot light, the more valuable MANF will become. It is gaining critical mass! Getting a couple orphan indications won't hurt MANF's growing momentum any.